Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma

Annals of Allergy, Asthma and Immunology

Volumn 97, Issue 6, 2006, Pages 761-766

  Iino, Yukiko ^a,b   Nagamine, Hisayo ^a   Kakizaki, Keiko ^a   Komiya, Takashi ^a   Katano, Hiroaki ^a   Saruya, Shoji ^a   Kodera, Kazuoki ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; ASTHMA; AUDITORY THRESHOLD; AUDITORY TUBE; BONE CONDUCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; EOSINOPHILIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE EAR EFFUSION; OTITIS MEDIA; OTORRHEA; PRIORITY JOURNAL; SPEECH ANALYSIS; STEROID THERAPY;

EID: 33845952433     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60967-2     Document Type: Article

References (17)

1. Tomioka S, Kobayashi T, Takasaka T. Intractable otitis media in patients with bronchial asthma (eosinophilic otitis media). In: Sanna M, ed. Cholesteatoma and Mastoid Surgery, Rome, Italy: CIC Edizioni Internazionali; 1997:851-853.
2. Nagamine H, Iino Y, Kojima C, et al. Clinical characteristics of so-called eosinophilic otitis media. Auris Nasus Laryx. 2002; 29:19-28.
3. Suzuki H, Matsutani S, Kawase T, et al. Epidemiologic surveillance of "eosinophilic otitis media" in Japan. Otol Jpn. 2004; 14:112-117.
4. Matsubara A, Kuroda R, Usami S, et al. The effect of topical administration of heparin to the eosinophilic otitis media. In: Takasaka T, Yuasa R, Hozawa K, eds. Recent Advances in Otitis Media. Bologna, Italy: Monduzzi Editore; 2001:403-406.
5. Matsutani S. Conservative treatment in patients with eosinophilic otitis media. MB ENT. 2002;18:62-66.
6. Iino Y. Eosinophilic inflammation in upper respiratory tract. Teikyo Med J. 2005;28:1-9.
7. Settipane GA. Nasal polyps: epidemiology, pathology, immunology and treatment. Am J Rhinol. 1987;1:119-126.
8. Haruna S, Yoshikawa M, Otori N, Moriyama H. Relationship between eosinophilic sinusitis and eosinophilic otitis media. Oto-Rhino-Laryngol Tokyo. 2003;46:472-480.
9. Uller L, Lloyd CM, Rydell-Tormanen K, et al. Effects of steroid treatment on lung CC chemokines, apoptosis and transepithelial cell clearance during development and resolution of allergic airway inflammation. Clin Exp Allergy. 2006;36:111-121.
10. Jayaram L, Pizzichini E, Lemiere C, et al. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast. Thorax. 2005;60:100-105.
11. ten Brinke A, Zwinderman AH, Sterk PJ, et al. Refractory eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med. 2004; 170:601-605.
12. Iino Y, Kakizaki K, Katano H, et al. Eosinophil chemoattractant in middle ear of patients with eosinophilic otitis media. Clin Exp Allergy. 2005;35:1370-1376.
13. Iino Y, Nagamine H, Yabe T. Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma. Clin Exp Allergy. 2001;31:1135-1143.
14. Nonaka M, Fukumoto A, Ozu C, et al. IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion. Acta Otolaryngol. 2003;123:383-387.
15. Melhus A, Ryan AF. Expression of cytokine genes during pneumococcal and nontypeable Haemophilus influenzae acute otitis media in the rat. Infect Immun. 2000;65:4024-4031.
16. Engel F, Blatz R, Schliebs R, et al. Bacterial cytolysin perturbs round window membrane permeability barrier in vivo: possible cause of sensorineural hearing loss in acute otitis media. Infect Immun. 1998;66:343-346.
17. Takumida M, Anniko M. Localization of endotoxin in the inner ear following inoculation into the middle ear. Acta Otolaryngol. 2004;124:772-777.